ClinVar Miner

Submissions for variant NM_000359.3(TGM1):c.1187G>T (p.Arg396Leu)

dbSNP: rs121918721
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000255177 SCV000321963 likely pathogenic not provided 2016-05-26 criteria provided, single submitter clinical testing The R396L likely pathogenic variant in the TGM1 gene has been report previously as R395L in Finnish patients diagnosed with lamellar ichthyosis and nonbullous congenital ichthyosiformis erythroderma (Laiho et al., 1997). It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. However, per the 1000 Genomes Consortium, the R396L variant was observed with a frequency of 1.5%, 3/198 alleles, in individuals of Finnish ancestry (McVean et al., 2014). Missense variants at the same (R396S/H) and in nearby residues (G392D, F401V) have been reported in the Human Gene Mutation Database in association with lamellar ichthyosis/ autosomal recessive congenital ichthyosis (Stenson et al., 2012), supporting the functional importance of this region of the protein. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded.
Invitae RCV000255177 SCV001407932 pathogenic not provided 2023-03-29 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg396 amino acid residue in TGM1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19500103, 23689228, 26762237, 27025581). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TGM1 protein function. ClinVar contains an entry for this variant (Variation ID: 12487). This variant is also known as Arg395Leu. This missense change has been observed in individuals with congenital ichthyosis (PMID: 9326318, 25766764, 27025581). This variant is present in population databases (rs121918721, gnomAD 0.07%). This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 396 of the TGM1 protein (p.Arg396Leu).
Genome-Nilou Lab RCV000013309 SCV002763640 likely pathogenic Autosomal recessive congenital ichthyosis 1 criteria provided, single submitter clinical testing
OMIM RCV000013309 SCV000033555 pathogenic Autosomal recessive congenital ichthyosis 1 1997-09-01 no assertion criteria provided literature only
Counsyl RCV000013309 SCV000793010 likely pathogenic Autosomal recessive congenital ichthyosis 1 2017-07-25 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.